Part - 2 IPC MCQ 11-25 Radio Pharmaceutical || PharmaEasyNotes || @Pharm...
- A.
They have a short half-life
- B.
They are brain specific agents which allows for delayed imaging
- C.
They have few side effects which allows for delayed imaging
- D.
They have a long half-life which allows for delayed imaging
ANS. B
- A.
The glucose component
- B.
The fluorine component
- C.
The phosphate component
- D.
The short half-life
ANS. A
- A.
Tumors are hypometabolic and require less fluorine than most normal tissues
- B.
Tumors are hypometabolic and require less sugar than most normal tissues
- C.
Tumors are hypermetabolic and require more fluorine than most normal tissues
- D.
Tumors are hypermetabolic and require more sugar than most normal tissues
ANS. D
- A.
By tagging red blood cells with radioactivity
- B.
By tagging somatostatin receptors with radioactivity
- C.
By tagging white blood cells with radioactivity
- D.
By inhaling radioactive gas
ANS. C
- A.
Because the brain uses fluorine for energy
- B.
Because the brain uses glucose for energy
- C.
Because diseased brain tissue requires an excess of glucose
- D.
Because diseased brain tissue requires an excess of fluorine
ANS. B
- A.
True
- B.
False
ANS. B
- A.
To evaluate for pulmonary embolism
- B.
To evaluate for COPD
- C.
To assess lung function pre or post-surgery
- D.
All of the above
ANS. C
- A.
A sedative
- B.
A diuretic
- C.
IV saline
- D.
An anesthetic
ANS. B
- A.
Liver
- B.
Stomach
- C.
Intestine
- D.
Gallbladder
ANS. D
- A.
It’s easy to digest
- B.
It’s tasteless
- C.
It is not absorbed by surrounding tissues
- D.
It’s easily absorbed by surrounding tissues
ANS. C
- A.
Subcutaneously
- B.
Intravenously
- C.
Orally
- D.
None of the above
ANS. A
- A.
They have a longer half-life
- B.
They have a higher energy
- C.
They have a shorter half-life
- D.
A & b
- E.
B & c
ANS. D
- A.
Gamma
- B.
Beta
- C.
Positron
- D.
A & b
- E.
B & c
ANS. D
- A.
P-32
- B.
Sr-89
- C.
Sm-153
- D.
I-131
ANS. C
- A.
They can both be imaged for evaluation of biodistribution
- B.
They both target the CD20 antigen on B-lymphocytes
- C.
They both are used to treat Non-Hodgkin’s Lymphoma
- D.
A & b
- E.
B & c
ANS. E
Comments
Post a Comment